Tadalafil Tablet, Film Coated
Product Images NDC 63629-8409

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 63629-8409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298409)

Label (Lbl636298409)
This is a package of Tadalafil 2.5mg tablets, oval-shaped and white in color, packaged by Bryant Ranch Prepack. It is to be stored at room temperature and should be kept away from children. The product can be compared to Cialis 2.5mg tablets. The package contains 90 tablets and the expiration date is not provided. The NDC number is 6362984091 08409901523487.*
FDA Label Image

Figure (Tadalafil Figure1)

Figure (Tadalafil Figure1)
This is a table showing the difference between Tadalafil and placebo in terms of blood pressure (measured in mmHg) for standing and supine systolic and diastolic BP. The time in hours is also shown.*
FDA Label Image

Figure (Tadalafil Figure2)

FDA Label Image

Figure (Tadalafil Figure3)

FDA Label Image

Figure (Tadalafil Figure4)

Figure (Tadalafil Figure4)
This is a graph that shows the concentration of Tadalafil in plasma at different time intervals after administering a single 20mg dose, a single 5mg dose, and a once-daily 5mg dose for 5 consecutive days. The unit of measurement is micrograms per liter (ug/L). Time is measured in hours and is shown on the x-axis. If any text present besides this, it is not readable.*
FDA Label Image

Figure 5 (Tadalafil Figure5)

Figure 5 (Tadalafil Figure5)
This is a graph that shows the Change from Baseline in IPSS Total Score for Tadalafil (measured in mg) compared to a placebo. There is a significant difference between the two groups with a p value of less than 0.01. The x-axis represents the duration of treatment in weeks, with 4, 8, and 12-week marks.*
FDA Label Image

Figure 6 (Tadalafil Figure6)

FDA Label Image

Figure 7 (Tadalafil Figure7)

FDA Label Image

Figure 8 (Tadalafil Figure8)

FDA Label Image

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.